I have been reading comments here about BRN being 6 years ahead of the competition with the work being done on AKIDA 2000 and 3000.
How can we be at all confident in these sorts of statements ?
The nature of ground breaking IP development is generally shrouded in secrecy and NDA’s …….eg. 4DS. Surely we have no way of knowing for what our competitors are doing behind locked doors.
I am keen to hear from anyone who can give
me reason to believe we have this much advantage.
On a side issue, I can imagine many product and chip developers being extremely interested in the myriad opportunities AKIDA offers in providing eg. efficiency solutions. For obvious reasons I can imagine many interested parties will want to take on a license but not broadcast this to competitors. I wonder how much of our business will fall under non-disclosure agreements, particularly in the near future???
We may not be told who all of our clients are …… even the big contracts . We will just notice a large amount of income showing up on the balance sheet.
Any thoughts ?
- Forums
- ASX - By Stock
- BRN
- 2021 BRN Discussion
2021 BRN Discussion, page-31994
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $522.7M |
Open | High | Low | Value | Volume |
26.5¢ | 27.0¢ | 26.0¢ | $2.161M | 8.144M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 431626 | 26.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.0¢ | 399533 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 428226 | 0.265 |
41 | 1046284 | 0.260 |
24 | 855849 | 0.255 |
62 | 1249850 | 0.250 |
17 | 439679 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.270 | 389533 | 12 |
0.275 | 879418 | 20 |
0.280 | 1144172 | 22 |
0.285 | 874654 | 24 |
0.290 | 1047484 | 20 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online